BioStock: Torgny Stigbrand invests in Lipum

In October, Lipum carried out a directed share issue of approximately 39 MSEK to finance the recently initiated phase I study with SOL-116. The share issue was fully subscribed and attracted both existing and new investors. Professor Torgny Stigbrand is one of the new owners who has chosen to invest in Lipum with a pronounced long-term interest in the company. BioStock had a chat with Stigbrand about his background and expertise in monoclonal antibodies and his thoughts on investing in Lipum.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/11/torgny-stigbrand-invests-in-lipum/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/